Eisler Capital (Uk) Ltd. Abbott Laboratories Call Options Transaction History

Eisler Capital (Uk) Ltd.

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $534,273 - $630,696	5,339 Added 3.37%	163,980 $18.7 Million
Q2 2024 Aug 13, 2024	BUY	$100.73 - $112.44 $3.72 Million - $4.15 Million	36,895 Added 30.3%	158,641 $16.5 Million
Q1 2024 May 14, 2024	BUY	$109.52 - $120.96 $5.27 Million - $5.82 Million	48,080 Added 65.27%	121,746 $13.8 Million
Q4 2023 Feb 13, 2024	BUY	$90.19 - $110.4 $3.32 Million - $4.07 Million	36,826 Added 99.96%	73,666 $8.11 Million
Q3 2023 Nov 13, 2023	BUY	$95.53 - $114.62 $3.52 Million - $4.22 Million	36,840 New	36,840 $3.57 Million

3,187

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Eisler Capital (Uk) Ltd., based on Form 13F filings with the SEC.

Stay updated on Eisler Capital (Uk) Ltd. with notifications on news.